Navigating the Chaos

" If you ’re not confused, you’re not paying attention.”This quote from best-selling author and business guru Tom Peters ’Thriving On Chaos could have been written for pharma right now.Megatrends disrupt the landscape, while political and economic uncertainties make predicting the future a fool ’s game. Chaos is everywhere, not least in patient access.How companies respond may well have a lot to do with that eternal question – is the glass half-full or half-empty?“I like the uncertainty that chaos brings in filling up that glass,” says John A. Bardi, VP, Public Affairs and Digital Medicine Business Development, at Otsuka. “Business performance uncertainty facing all US healthcare ecosystem stakeholders requires leaders to anticipate better, think smart er, pivot more quickly, and be open to experimenting with new market approaches based on the generation of real-world evidence (RWE) about our products. MeaningfulRWE is clearly emerging as a new norm necessary for securing patient and prescriber access to our products. ”The value of R&D A scientist by training, Debbie Drane, SVP, Commercial Development, at CSL Behring, can understand the reluctance of scientists to engage in discussions around value. “My research guys are still struggling. [They say:] “But it really works” or “It’s going to fit an unmet need.” But when I ask, “Yes, but what’s the value to the patient or the physician or the payer?” they can’t speak that language.”...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news